Pulse Biosciences, Inc. (PLSE)

6.86 0.00 (0.00%) At close: 04:00PM EDT

Pulse Biosciences, Inc.

3957 Point Eden Way
Hayward, CA 94545
United States
510 906 4600
https://www.pulsebiosciences.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Robert W. Duggan	Executive Chairman	N/A	N/A	1945
Mr. Kevin P. Danahy	President & CEO	834.73k	N/A	1972
Mr. Darrin R. Uecker	CTO & Director	834.73k	N/A	1966
Mr. Mitchell E. Levinson	Chief Strategy Officer	584.57k	N/A	1960
Dr. Richard Nuccitelli Ph.D.	Chief Science Officer	N/A	N/A	N/A
Mr. Kenneth B. Stratton Esq., J.D.	General Counsel & Corporate Secretary	N/A	N/A	1969
Ms. Patty Perla	Vice President of Human Resources	N/A	N/A	N/A
Mr. David Danitz	Senior Vice President of Engineering	N/A	N/A	N/A
Dr. Gansevoort Dunnington M.D.	Chief Medical Officer	N/A	N/A	N/A
Dr. Niv Ad M.D.	Chief Science Officer of Cardiac Surgery	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Corporate Governance

Pulse Biosciences, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 8. The pillar scores are Audit: 3; Board: 9; Shareholder Rights: 6; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.